CureVac and the University Medical Center Mainz Start Phase 3 Clinical Trial for COVID-19 Vaccine Candidate, CVnCoV, in Healthcare Workers,

Study builds on observational epidemiological study TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / December 21, 2020 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company …, Study builds on observational epidemiological study TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / December 21, 2020 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company …, Read More

Scroll to Top